000			nam a22 i 4500
999			_c6596 _d6596
001			6596
003			ES-MaCNC
005			20230113114451.0
007			ta
008			230112s2022 -uk ||||r|||| 000 0 eng d
020			_a978-1-83862-882-6
040			_aES-MaCNC _cES-MaCNC
245	0	4	_aThe guide to life sciences
260			_aLondon _bLaw Business Research _c2022
300			_a278 p. _c24 cm.
336			_2isbdcontent _aTexto (visual)
337			_2isbdmedia _asin mediación
490	1		_aGlobal Competition Review (GCR)
500			_aEditores: Ingrid Vandenborre, Caroline Janssens. Autores: John Davies, Valérie Meunier, Rameet Sangha, David Sevy, George Zacharodimos, Avantika Chowdhury, Adriano Barbera, Sam Carr, Marta Giner Asins, Arnaud Sanz, Miranda Cole, Luca Ghafelehbashi, Julien Haverals, Maria Raptis, Michael Frese, Julia Zhu, Marta Navarro Hernández, Niels Christian Ersbøll, Elizabeth Avery, Susan Jones, Salomé Cisnal de Ugarte, Geneviève Michaux, Mélanie Perez, Ivan Pico, Georgios Symeonidis, Adrien Giraud, Eveline Van Keymeulen, Julien Morize, Jeanne Fabre, Tobias Maier, Martin Bechtold, Aurelius Freytag, Karin Köller, Maria Balestriero, Enzo Marasà, Irene Picciano, Elisa Stefanini, Claudio Todisco, Jan Truijens Martinez, Florentine Snoeker, Philipp Zurkinden, Bernhard C Lauterburg, Andrea Schütz, Marino Baldi, Robert Eriksson, Gustaf Duhs, Arman Oruc, Andrew Lacy, Elliot Silver, Brady Cummins.
520			_aThe covid-19 pandemic – and the amount of public money that governments are spending on healthcare – has thrust the life sciences industry into the nternational spotlight, with debates over price controls and IP waivers making headlines around the world. While many of these concerns are global, the same is not always true of the solutions adopted by national regulators. The fi rst edition of The Guide to Life Sciences – edited by Ingrid Vandenborre and Caroline Janssens – provides practical and timely guidance for both practitioners and enforcers trying to navigate this high-stakes environment. The Guide draws on the wisdom and expertise of distinguished practitioners globally to provide essential guidance on subjects as diverse as biosimilar competition and product denigration, as well as a forensic examination of the most signifi cant and far-reaching regulations and decisions from around the world. <br> <b>TABLE OF CONTENTS</b> <br> - Introduction. Ingrid Vandenborre and Caroline Janssens Skadden, Arps, Slate, Meagher & Flom LLP <br> - An Economist’s Perspective. John Davies, Valérie Meunier, Rameet Sangha and David Sevy. Compass Lexecon <br> - Excessive Pricing. George Zacharodimos. Skadden, Arps, Slate, Meagher & Flom LLP <br> - Biosimilar Competition: an Economist’s Perspective. Avantika Chowdhury, Adriano Barbera and Sam Carr. Oxera Consulting LLP <br> - Product Denigration. Marta Giner Asins and Arnaud Sanz. Norton Rose Fulbright <br> - Merger Control: Procedural Issues. Miranda Cole, Luca Ghafelehbashi and Julien Haverals. Norton Rose Fulbright <br> - Merger Control: Substantive Issues. Maria Raptis, Michael Frese, Julia Zhu and Marta Navarro Hernández. Skadden, Arps, Slate, Meagher & Flom LLP <br> - Cooperative Agreements: a Private Practitioner’s Perspective. Niels Christian Ersbøll. Arnold & Porter Kaye Scholer LLP <br> - Australia: ACCC’s Focus on Conduct Could Have Far-Reaching Implications. Elizabeth Avery and Susan Jones. Gilbert + Tobin <br> - European Union: Commission Still at the Forefront, While Pay-for-Delay Cases Set New Precedents. Salomé Cisnal de Ugarte, Geneviève Michaux, Mélanie Perez, Ivan Pico and Georgios Symeonidis. King & Spalding LLP <br> - France: FCA Increases Scrutiny Over the Sector. Adrien Giraud, Eveline Van Keymeulen, Julien Morize and Jeanne Fabre. Latham & Watkins LLP <br> - Germany and Austria: Post-Covid Collaboration is on the Rise in this Key Economic Sector. Tobias Maier, Martin Bechtold, Aurelius Freytag and Karin Köller. Eversheds Sutherland <br> - Italy: Antitrust Pioneer Continues to Break Ground on Theories of Harm. Maria Balestriero, Enzo Marasà, Irene Picciano, Elisa Stefanini and Claudio Todisco. Portolano Cavallo <br> - Netherlands: Price and Supply Security Remain Regulator’s Top Priorities. Jan Truijens Martinez and Florentine Snoeker. Stibbe <br> - Switzerland: Merger Control Reform Could Have Big Impact, Especially for ‘National’ Markets. Philipp Zurkinden, Bernhard C Lauterburg, Andrea Schütz and Marino Baldi. Prager Dreifuss Ltd <br> - United Kingdom: a Key Jurisdiction for Competition Law Compliance. Robert Eriksson and Gustaf Duhs. Stevens & Bolton <br> - United States: FTC Looks Set to Open up New Enforcement Front. Arman Oruc, Andrew Lacy, Elliot Silver and Brady Cummins. Goodwin Procter LLP <br>
650		4	_aCompetencia _9203
650		4	_aDerecho de la competencia _9356
650		4	_aFusiones y adquisiciones _9589
653		0	_aBiotecnología
653		0	_aControl de precios
653		0	_aPrácticas anticompetitivas
653		0	_aDefensa de la competencia
653		0	_aProductos farmacéuticos
653		0	_aConcentración de empresas
653		0	_aControl de concentraciones
653		0	_aAcuerdos de cooperación
653		0	_aCooperación internacional
653		0	_aAntitrust
653		0	_aTeoría de daños
653		0	_aPrecios excesivos
653		0	_aCumplimiento normativo (Compliance)
700	1		_aVandenborre, Ingrid _eed. lit. _97639
710	1		_aJanssens, Caroline _eed. lit. _97640
830			_aGlobal Competition Review (GCR) _97268
856	4	1	_uhttps://globalcompetitionreview.com/guide/guide-life-sciences/first-edition _zVer ebook
856	4	1	_uhttp://bibliotecacnmc.bage.es/cgi-bin/koha/opac-retrieve-file.pl?id=a2847d3f0a14f95990c9a1421175949e _yVer índice
942			_2udc _cMON